Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ASPIRA MEDICAL Aktiebolag
AB
Active
Org 5564471539
Gimsbärke 326, 781 90
Borlänge
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 1992
9 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ASPIRA MEDICAL Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
13M
26M
39M
52M
22M
2021
23M
2022
45M
2023
31M
2024
35M
2025
EBITDA
SEK millions
0M
1M
2M
3M
5M
1M
2021
1M
2022
4M
2023
2M
2024
4M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
21 531
22 623
44 773
31 267
35 405
Staff expenses
—
−6 671
−7 712
−7 558
−7 721
EBITDA
1 002
1 075
4 421
1 679
4 110
Depreciation & amort.
−0
—
−7
−16
−22
EBIT
1 002
1 075
4 414
1 663
4 089
Net financials
—
−15
31
122
26
Profit before tax
1 002
1 060
4 703
1 785
4 114
Tax
−225
−225
−978
−373
−855
Net profit
777
834
3 725
1 411
3 259
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
10 460
11 136
16 607
13 234
15 065
Equity
6 028
6 326
9 491
8 463
10 690
Long-term debt
0
—
—
—
—
Short-term debt
4 174
4 552
7 115
4 771
4 374
Total debt
4 174
4 552
7 115
4 771
4 374
Financial ratios
5-year trend
EBITDA margin
11.6%
This company
15.8%
Market median
-27% vs market
2021
2025
Equity ratio
71.0%
This company
38.2%
Market median
+86% vs market
2021
2025
Return on equity
30.5%
This company
18.4%
Market median
+66% vs market
2021
2025
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
2021
2025
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
2021
2025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on ASPIRA MEDICAL Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
